Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
Texas Tech University Health Sciences Center
Not signed up.
Genomic Characterization of Diabetic Gastroparesis
To date, little is known in regards to the genetic alterations which accompany the onset of gastroparesis (GP) which affects 30-65% of diabetic patients. The goal of this study is to characterize unique changes in RNA expression in gastric tissue and serum of diabetic, gastroparetic patients to identify the molecular pathways that lead to gastric dysfunction. To do this, we have been approved to use serum and gastric tissue samples collected by the Gastroparesis Clinical Research Consortium (GpCRC) on which we propose to isolate mRNA (from gastric tissues) and miRNA (from serum and gastric tissues). These serum and tissue samples are from symptomatic diabetics, who have documented delayed emptying of the stomach, have glucose control with HA1c < 10, no renal impairment (creatinine <2.0 mg/dl) and no active malignancy. Our control group will include diabetic patients who have no symptoms of gastroparesis, have no peripheral neuropathy, have good glucose (HbA1c<10), creatinine <2mg/dl and no malignancy. Once isolated and hybridized to expression arrays, these RNA samples will help to identify genes uniquely expressed or absent in the experimental (diabetic, gastroparetic) vs. control (diabetic-only) group. Briefly we will isolate circulating miRNA from serum-exosomes or mRNA and miRNA from paraffin-embedded gastric tissue samples using commercially available and highly optimized kits. Once isolated, the RNA will be assayed for integrity, and if suitable, amplified, and properly labeled for hybridization onto either whole genome microarray or microRNA expression arrays. Hybridized signal intensities will be assayed and analyzed for statistical significance using appropriate microarray software. Upon completion of this project, we expect to identify clusters of mRNA and microRNA changes on which we can apply pathway analysis software to identify putative pathways that regulate or are regulated by these genes. If awarded, this very sophisticated genetic research project could be recognized as a scientific bridge between two Consortiums, GPCRC and DCC focusing on the same population of patients and their clinical complications.
Drag a column header and drop it here to group by that column
Genomic Characterization of Diabetic Gastroparesis (Sarosiek, Irene)
View Progress Report Document
No uploaded documents found.
Year: 2015; Items: 1
Outcomes and Factors Associated With Reduced Symptoms in Patients with Gastroparesis.
Pasricha PJ, Yates KP, Nguyen L, Clarke J, Abell TL, Farrugia G, Hasler WL, Koch KL, Snape WJ, McCallum RW, Sarosiek I, Tonascia J, Miriel LA, Lee L, Hamilton F, Parkman HP
Year: 2012; Items: 1
Prokinetics in diabetic gastroparesis.
Hejazi RA, McCallum RW, Sarosiek I
Current gastroenterology reports
, 2012 (14), 297 - 305
Year: 2011; Items: 3
Does grading the severity of gastroparesis based on scintigraphic gastric emptying predict the treatment outcome of patients with gastroparesis?
Hejazi RA, Sarosiek I, Roeser K, McCallum RW
Digestive diseases and sciences
, 2011 (56), 1147 - 1153
Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years.
McCallum RW, Lin Z, Forster J, Roeser K, Hou Q, Sarosiek I
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
, 2011 (9), 314 - 319.e1
Two-channel gastric pacing in patients with diabetic gastroparesis.
Lin Z, Sarosiek I, Forster J, Ross RA, Chen JD, McCallum RW
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
, 2011 (23), 912 - e396
No uploaded documents found.
No protocols found.
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
The DiaComp Gastro-Intestinal (GI) Committee has the principal function of furthering the mission of the consortium with regard to diabetic gastro-intestinal (GI) and liver disease
Curation Flag Information
New comment to be added:
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!